Clinical experience with glynclamide, a new hypoglycaemic agent.
作者信息
Burns F H
出版信息
Med J Aust. 1969 Aug 30;2(9):436-9.
PMID:4898056
Abstract
摘要
相似文献
1
Clinical experience with glynclamide, a new hypoglycaemic agent.新型降糖药格列本脲的临床经验
Med J Aust. 1969 Aug 30;2(9):436-9.
2
[Differential therapy using oral antidiabetics].[使用口服抗糖尿病药物的差异疗法]
Internist (Berl). 1971 Nov;12(11):468-75.
3
[Clinical report of the experience in therapy with oral antidiabetic agent HB 419].[口服抗糖尿病药物 HB 419 的治疗经验临床报告]
Wien Klin Wochenschr. 1969 Sep 5;81(36):625-8 passim.
4
[Long term efficacy and tolerance of antidiabetic treatments. New data].[抗糖尿病治疗的长期疗效和耐受性。新数据]
Nouv Presse Med. 1974 Jun 15;3(24):1551-4.
5
[Results of diabetes therapy with Silubin retard].[水飞蓟宾缓释片治疗糖尿病的结果]
Med Klin. 1966 Apr 15;61(15):592-6.
6
[Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)].
Dtsch Med Wochenschr. 1969 Apr 18;94(16):824-9. doi: 10.1055/s-0028-1111125.
7
[Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].[新型磺脲类药物格列吡嗪治疗糖尿病的评估]
Minerva Med. 1973 Oct 10;64(71):3725-31.
8
Plasma insulin studies in two hundred patients with diabetes mellitus.对200名糖尿病患者的血浆胰岛素研究。
Q J Med. 1969 Oct;38(152):445-65.
9
[Late failures of oral therapy of diabetes].[糖尿病口服治疗的晚期失败]
Dtsch Z Verdau Stoffwechselkr. 1965 Nov;25(5):305-12.
10
[Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].用新型磺脲类药物甲苯磺丁脲口服治疗糖尿病
Arzneimittelforschung. 1969 Jul;19(7):1128-30.
引用本文的文献
1
Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy.与格列本脲治疗相关的肝内胆汁淤积和皮肤大疱
Postgrad Med J. 1981 Apr;57(666):244-6. doi: 10.1136/pgmj.57.666.244.
2
Glibenclamide: a review.
Drugs. 1971;1(2):116-40. doi: 10.2165/00003495-197101020-00002.
Zotero 插件